Abstract
The first sections herein cover the impact of infection on healing of experimental wounds (p. 2), the importance of biofilms (p. 4), and a general overview of the microbiology of DFIs (p. 6). Although debridement of DFUs was covered in the first compendium, we deemed it important enough to include here as well, given its pivotal role in the management of DFIs. Subsequent sections cover the management of infected DFUs (p. 9) and discussions of antibiotics versus surgery for osteomyelitis (p. 12) and the OVIVA trial (p. 13). There is little doubt that the OVIVA trial will challenge the current management of osteomyelitis, in which IV antibiotics are still commonly used. The remaining sections cover potential topical treatments for DFIs (p. 15) and the role of modern technology in infection control (p. 17).
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
